Patient Follow up Model to this guide Map - IDEA4RC FHIR Implementation Guide v0.1.0

IDEA4RC FHIR Implementation Guide
0.1.0 - CI Build 150

IDEA4RC FHIR Implementation Guide, published by IDEA4RC Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/idea4rc/ and changes regularly. See the Directory of published versions

ConceptMap: Patient Follow up Model to this guide Map (Experimental)

Official URL: http://hl7.eu/fhir/ig/idea4rc/ConceptMap/followup2FHIR				Version: 0.1.0
Draft as of 2024-11-12				Computable Name: Followup2FHIR

Patient Follow up Model to this guide Map

It shows how the Patient Follow up model is mapped into this guide

Generated Narrative: ConceptMap followup2FHIR

Mapping from Patient Follow Up to http://hl7.eu/fhir/ig/idea4rc/StructureDefinition//Bundle-eu-i4rc

Group 1 Mapping from Patient Follow Up to Encounter: IDEA4RC

Source Code

Relationship

Target Code

Comment

PatientFollowUp.patient (Patient)

is equivalent to

Encounter.subject

PatientFollowUp.statusAtLastFollowUp (Status at last follow-up)

is related to

Encounter.diagnosis.condition

THE STATUS AS DESCRIBED IN THE MODEL IS MAPPED INTO A SEPARET OBSERVATION (see below) If intended as the diagnosis at the last follow up. use = $diagnosis-role#AD (AdmissionDiagnosis) Details in the referred Condition

PatientFollowUp.patientFollowUpDate (Patient Follow Up date)

is related to

Encounter.period.start

PatientFollowUp.newCancerDiagnosis (New cancer diagnosis)

is related to

Encounter.diagnosis.condition

Where use = $diagnosis-role#DD (Discharge Diagnosis) Details in the referred Condition

PatientFollowUp.dateOfNewCancerDiagnosis (Date of new cancer diagnosis)

is related to

Encounter.diagnosis.condition

Where use = $diagnosis-role#DD (Discharge Diagnosis) Details in the referred Condition

PatientFollowUp.newCancerTopography (New cancer topography)

is related to

Encounter.diagnosis.condition

Where use = $diagnosis-role#DD (Discharge Diagnosis) Details in the referred Condition

Group 2 Mapping from Patient Follow Up to Condition: Primary Cancer

Source Code

Relationship

Target Code

Comment

PatientFollowUp.patient (Patient)

is equivalent to

Condition.subject

PatientFollowUp.statusAtLastFollowUp (Status at last follow-up)

is equivalent to

Condition.clinicalStatus

THE STATUS AS DESCRIBED IN THE MODEL IS MAPPED INTO A SEPARET OBSERVATION (see below) If intended as the diagnosis at the last follow up. use = $diagnosis-role#AD (AdmissionDiagnosis) Details in the referred Condition

PatientFollowUp.patientFollowUpDate (Patient Follow Up date)

(not mapped)

PatientFollowUp.newCancerDiagnosis (New cancer diagnosis)

is equivalent to

Condition.code

Parent Encounter.diagnosis with use = $diagnosis-role#DD (Discharge Diagnosis)

PatientFollowUp.dateOfNewCancerDiagnosis (Date of new cancer diagnosis)

is equivalent to

Condition.onSetDateTime

Parent Encounter.diagnosis with use = $diagnosis-role#DD (Discharge Diagnosis). See the CancerEpisode map for further details about the representation of the date of diagnosis

PatientFollowUp.newCancerTopography (New cancer topography)

is equivalent to

Condition.bodySite

Parent Encounter.diagnosis with use = $diagnosis-role#DD (Discharge Diagnosis)

Group 3 Mapping from Patient Follow Up to Observation: Status at the Last Follow Up

Source Code

Relationship

Target Code

PatientFollowUp.patient (Patient)

is equivalent to

Observation.subject

PatientFollowUp.statusAtLastFollowUp (Status at last follow-up)

is equivalent to

Observation.valueCodeableConcept

Group 4 Mapping from Patient Follow Up to Observation: date of the last contact

Source Code

Relationship

Target Code

PatientFollowUp.patient (Patient)

is equivalent to

Observation.subject

PatientFollowUp. (Patient Follow Up date)

is equivalent to

Observation.valueDateTime

Links: Table of Contents | QA Report

The IDEA4RC project has received funding from the European Union's Horizon 2020
research and innovation programme under grant agreement No. 101057048.